User menu

The roles of alpha-glucosidase inhibitors in diabetes.

Bibliographic reference Donckier, Julian ; Williams, G.. The roles of alpha-glucosidase inhibitors in diabetes.. In: European journal of clinical investigation, Vol. 24, no. 8, p. 522-4 (1994)
Permanent URL
  1. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus, 10.1056/nejm199309303291401
  2. Williams G, Management of non-insulin-dependent diabetes mellitus, 10.1016/s0140-6736(94)90822-2
  3. Puls W., Keup U., Influence of an ??-amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and nefa in starch loading tests in rats, dogs and man, 10.1007/bf01230687
  4. HOLMSEN H., Significance of testing platelet functionsin vitro, 10.1111/j.1365-2362.1994.tb02418.x
  5. Puls W., Keup U., Krause H. P., Thomas G., Hoffmeister F., Glucosidase inhibition : A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia, 10.1007/bf00483562
  6. Balfour JA, Drugs, 46, 1025 (1993)
  7. Kingma P. J., Menheere P. P., Sels J. P., Kruseman A. C. N.,  -Glucosidase Inhibition by Miglitol in NIDDM Patients, 10.2337/diacare.15.4.478
  8. Clissold SP, Durgs, 35, 214 (1988)
  9. Lefebvre PJ, New aspects in diabetes. Treatment strategies with alpha-glucosidase inhibitors (1992)
  10. Reuser AJJ, Eur J Clin Invest, 24, 19 (1994)
  11. Goke B, Eur J Clin Invest, 24, 25 (1994)
  12. Toeller M., Eur J Clin Invest, 24 (1994)
  13. Hanefeld M., Fischer S., Schulze J., Spengler M., Wargenau M., Schollberg K., Fucker K., Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone, 10.2337/diacare.14.8.732
  14. Hotta N, Diabetic Medicine, 10, 134 (1993)
  15. Reaven G. M., Lardinois C. K., Greenfield M. S., Schwartz H. C., Vreman H. J., Effect of Acarbose on Carbohydrate and Lipid Metabolism in NIDDM Patients Poorly Controlled by Sulfonylureas, 10.2337/diacare.13.3.32
  16. Johnston P. S., Coniff R. F., Hoogwerf B. J., Santiago J. V., Pi-Sunyer F. X., Krol A., Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients, 10.2337/diacare.17.1.20
  17. Rios MS., Eur J Clin Invest, 24, 36 (1994)
  18. Dimitriades G, Horm Metab Res, 18, 253 (1986)
  19. Lefebvre PJ, Eur J Clin Invest, 24, 40 (1994)
  20. Attwood D., Agarwal S.P., Self-association of disodium cromoglycate in dilute aqueous solution, 10.1016/0378-5173(84)90042-5
  21. Ladas S D, Frydas A, Papadopoulos A, Raptis S A, Effects of alpha-glucosidase inhibitors on mouth to caecum transit time in humans., 10.1136/gut.33.9.1246
  22. Scheen AJ, Eur J Clin Invest, 24, 50 (1994)